Anti‐mitotic agent SB‐216 overcomes taxane resistance in castration‐resistant prostate cancer and exhibits anti‐tumour efficacy in pancreatic cancer

Rui Wang, Wěi Li|British Journal of Pharmacology|2025

Cited by 0